Thrombin Generation in Beta-thalassemia Major — TG-THAL

Beta Thalassemia Major Anemia Clinical Trial

Official title:
Evaluation of Hypercoagulability by Thrombin Generation Test in Beta-thalassemia Major

Status Not yet recruiting

Clinical Trial Summary

This study aims to evaluate the persistence of a hypercoagulable state in chronically-transfused patients with beta thalassemia major, by using the thrombin generation test (performed in whole blood and plasma). Patients will be compared with 2 control groups: 1/ healthy volunteers and 2/ carriers of beta-thalassemia trait

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04962984
Study type	Interventional
Source	Central Hospital, Nancy, France
Contact
Status	Not yet recruiting
Phase	N/A
Start date	September 1, 2021
Completion date	September 1, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05693909` - A Trial Testing SP-420 in Subjects With Transfusion-dependent β-thalassemia	Phase 2
Completed	`NCT03591575` - Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children	Phase 4
Completed	`NCT03948737` - The Effect of Alpha-tocopherol in Hemolysis and Oxidative Stress Marker on the Red Cell Membrane Beta-thalassemia Major	N/A
Recruiting	`NCT02984475` - The Potential Hepatoprotective Effect of Metformin in Patients With Beta Thalassemia Major	Phase 4